Navigation Links
Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
Date:3/26/2008

Conference Call to be Held on Thursday, March 27, 2008

(7:00 p.m. Singapore Time and 7:00 a.m. Eastern Time)

SINGAPORE and MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that Bio*One Capital Pte. Ltd., one of the largest dedicated biomedical investment management companies in Asia, has committed to purchase $10 million of common stock in Alexza. The investment by Bio*One is being made in conjunction with Alexza's formation of Alexza Singapore Pte. Ltd., a wholly owned subsidiary. Alexza intends to initiate manufacturing operations for key components of Alexza's single-dose Staccato(R) device in Singapore. Alexza's single-dose Staccato devices are used in a majority of its current product candidates, including its lead program, AZ-004 (Staccato loxapine), which is in Phase 3 clinical testing for the treatment of acute agitation in schizophrenic or bipolar disorder patients.

"A key element of Alexza's commercial manufacturing strategy is the development of production for the Staccato device-related plastic and electronics components of our commercial product single-dose device," said Thomas B. King, President and CEO of Alexza. "Singapore provides an excellent location and environment for us to establish this important aspect of our commercial manufacturing plan. I believe the rich talent pool and in-depth expertise available in Singapore will be a key element for successful manufacturing operations."

"Alexza's technology and Staccato device offer patients a new paradigm to rapid systemic drug delivery through deep lung inhalation. We believe that combining Alexza's unique technology and Singapore's strengths in medical technology will f
'/>"/>

SOURCE Alexza Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
2. 19th Annual Piper Jaffray Health Care Conference to Webcast Alexzas Corporate Presentation
3. Alexza Elects Dr. Hal V. Barron to Its Board of Directors
4. Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
5. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
6. Alexzas Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference
7. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
8. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
9. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
10. H2Diesel Completes 3 Million Gallon Per Year Pilot Facility
11. AEterna Zentaris completes management team with the appointment of Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-FirstCall/--Sigma-AldrichCorporation(Nasdaq: SIAL...y,December1stat1:45PMGMTinLondon,7:45AMUS/CST.Inte...Internetavailableat http://inve s tor.sig m a...accessthisfile. ,, AboutSigma-Aldrich: Sigma...any.Itschemicalandbiochemicalproductsandkitsareuse...
(Date:11/24/2009)...-Asia/--ShanghaiBiolaxyannouncedthe,ChineseStateFo...stigationalnewdrugapplication(IND)foritsoralinsuli...treatdiabetes.ThisIND,approvalallowsBiolaxytoiniti...disordercharacteristicofhighbloodglucoseandpoor,me...veremicro-and,macro-vasculardiseases,lossofvision,...
(Date:11/24/2009)...re-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),t...nouncedthatithassubmittedaMAAtotheEuropeanMedicine...lacementtherapyindevelopment,forthetreatmentofType...nforvelaglucerasealfathathasbeensubmitted,withprev... Basedonaglobalsupplyshortageofthecurrentlyapprove...
(Date:11/24/2009)... Abstracts Service (CAS), the global expert on che...ice is now the world,s leading producer of patent ... Japan,s patent office, the World Intellectual Pro...atent and Trademark Office (USPTO) for more than a...6, and exceeded Japan for the first time on a mont...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...been following the Abbott Laboratories story reg... the government of Thailand over patent protection...a relatively isolated tiff between a single drug c...ider this to be a central - if not the central... a few - myself included - regard this to be one o...
... In many ways, Promega Corp . has given Northwes...mpany. , ,Quiet to those outside the life-science ...s suburban Madison walls, it,s anything but silent...hus far, that innovation has produced about 200 pa...ding 130 new product innovations since 2002. , ,Th...
...Advanced Cell Technology , the California biotechn...overed a way to extract stem cells from human embr... expanded commercialization agreement with the Wi...ent grants the company the right to the commercial...ous human therapies. , ,Advanced Cell Technology, ...
Other Biology Technology:Abbott vs. Thailand has implications for innovation and access 2Abbott vs. Thailand has implications for innovation and access 3Abbott vs. Thailand has implications for innovation and access 4Abbott vs. Thailand has implications for innovation and access 5Abbott vs. Thailand has implications for innovation and access 6Abbott vs. Thailand has implications for innovation and access 7Promega Corporation: Wisconsin's quiet innovator 2Promega Corporation: Wisconsin's quiet innovator 3Promega Corporation: Wisconsin's quiet innovator 4Promega Corporation: Wisconsin's quiet innovator 5WARF expands license agreement with Advanced Cell Technology 2
(Date:11/25/2009)...sors recently received funding from the National S...icial to understanding the environment. The three ...assistant professor in the Department of Biologica...rate research projects. , His first project, tit...Functions from the Leaf to the Landscape," will ex...
(Date:11/24/2009)...t may help gut bacteria bind to the gastrointestin...roducers to identify strains that are likely to be... interact with cells lining the gut to have a bene...he gut they are more likely to stick around long e...uge from the Institute of Food Research. IFR is a...
(Date:11/24/2009)...crets of the earth,s history locked in its icy dep...e information on the environments that have been s...Now, a team of researchers from nine institutions ...0 million dollars by the National Science Foundati...lly. These scientists will drill through the West ...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2A sticky solution for identifying effective probiotics 2LSU gets to the bottom of things -- in Antarctica 2MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 1MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 2MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 3Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 1Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 2Derma Sciences To Present at Rodman 26 Renshaws Eleventh Annual Healthcare Conference 55990 3NeurogesX to Present at Upcoming Fall Conferences 13797 1NeurogesX to Present at Upcoming Fall Conferences 13797 2NeurogesX to Present at Upcoming Fall Conferences 13797 3NeurogesX to Present at Upcoming Fall Conferences 13797 4
...Scientists at Washington University School of Medi... some of the bacteria that plague women with urina...uman bladder cells. , The finding confirms a cont...teria cause UTIs. Previously, most researchers ass...get into the bladder but do not invade the individ...
...ansmitters have consequences. They initiate events...e ability to move, to talk, to breathe, to think. ...right and sending proper signals downstream to mus...western University study reports that a mutation i...smitter in the nematode C. elegans causes an imbal...
...ndustry for the future in Sweden. However, to expl...demic and healthcare sectors will have to collabor...inical research. This is the conclusion of a joint...hnology (KTH), Karolinska Institutet and Karolinsk...record in the medtech field: Gambro, Getinge and E...
Other Biology News:Bacteria that cause urinary tract infections invade bladder cells 2Bacteria that cause urinary tract infections invade bladder cells 3Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3New report finds great potential for Swedish medical technology 2
Rabbit Anti-alpha-N-Catenin Polyclonal Antibody, Unconjugated from Cell Signaling Technology
BioDoc-It System from UVP
AC1 Auto System, OptiChemi™ Camera from UVP
Analog thermal printer, Mitsubishi (115/230V) for BioDoc-It and VisiDoc-It Imaging Systems from UVP
Biology Products: